The School-Conference will be held at N.D. Zelinsky Institute of Organic Chemistry RAS, Moscow, Russia.

Since its very start the Institute has been gathering the elite of Russian chemical community, including Professors A.E. Favorsky, N.D. Zelinsky, A.A. Balandin, I.N. Nazarov, I.L. Knunyants, V.V. Korshak, L.F. Vereshchagin, M.I. Kabanchik and many other outstanding scholars. 

Various globally acknowledged scientific schools and areas have been developing within the Institute, Profs. V.N. Ipatiev and A.E. Chichibabin's among them.

Nikolay D. Zelinsky headed one of the Institute's departments in 1936-53 and made a great contribution to the Institute advancement. He worked in various areas of organic chemistry, including theory and practice of the organic catalysis, hydrocarbon chemistry and oil refining. His studies in adsorption led to the creation of a carbon gas-mask that saved thousands of people in World War I. His inventions and scientific heritage brought fame to this country and Institute of Organic Chemistry. In 1953, the Institute received its present name – N.D. Zelinsky Institute of Organic Chemistry.

N.D. Zelinsky Institute of Organic Chemistry RAS (ZIOC RAS) is one of the largest centers for basic and applied research in the field of organic synthesis, physical-organic, bioorganic and specialty chemistry, and catalysis. The Institute implements prospective R&D projects in accordance with the technological priorities of the Russian Federation.

At present, the Institute’s overall goal in basic research is attaining new data on transformations and structure of organic compounds, mechanisms of chemical reactions, discovery of new reactions, synthesis of new classes of organic compounds, design of new catalysts and investigation of their structure/catalytic activity relationship, and development of novel scalable synthetic methods for preparing practically important organic compounds and new catalysts with valuable technical properties. ZIOC RAS is actively involved in bioorganic and medicinal chemistry research. It has developed and tested methodologies for the synthesis of new biologically active substances essential for designing new vaccines, antimycotic and anticancer drugs, and medical diagnosticums.